“cancer-drug” Archives

in
Entry Author Date Location
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold 08/18/20 San Diego
Jazz Pharma Gets Quick FDA OK for New Small Cell Lung Cancer Drug 06/15/20 National
ORIC Pharma Gets $120M in IPO to Advance Drug-Resistant Cancer Therapies 04/24/20 San Francisco
Zentalis Upsizes IPO, Raising $165M for Cancer Drug Clinical Trials 04/03/20 New York
SeaGen Adds Five Prime Therapeutics Antibodies in Licensing Deal 02/20/20 Seattle
Five Prime, Bristol Pancreatic Cancer Drug Combo Fails Phase 2 Test 02/18/20 San Francisco
Scripps Research’s Calibr to Test “Switchable” CAR-T in Clinical Trial 02/06/20 San Diego
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule 12/09/19 New York
Upjohn & Mylan to Merge, Freeing Pfizer to Focus on Biopharma R&D 07/29/19 New York
Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts 07/18/19 National
Black Diamond Gets $85M for Cancer Drugs R&D and New Cambridge HQ 01/10/19 Boston
Eying Clinical Trials, Shattuck Labs Adds $46M for Immunotherapy R&D 05/30/18 Texas
Raising $56M, Revolution Medicines Drops Old Work and Turns to Cancer 04/24/18 San Francisco
Vertex Deals Cancer Drugs to Merck KGaA for $230M, Following Plan 01/11/17 Boston
Clovis Oncology Shares Plummet on FDA Request for More Data 11/16/15 Boulder/Denver
Microsoft Sells Razorfish, EnerG2 Scores Stimulus Funds, Tekmira Teams Up with Alnylam, & More Seattle-Area Deals News 08/11/09 Seattle
Page 1 of 1